Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    16870917 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Spironolactone Versus Amiloride as an Add on Agent in Resistant Hypertension
Condition: Hypertension
Interventions: Drug: spironolactone;   Drug: amiloride

Study has passed its completion date and status has not been verified in more than two years.